Il Yang licensing out Ilaprazole to Tap Co.

Il yang announced on Sept. 7 that a technical transfer of Ilaprazole, an anti-peptic ulcer drug, was agreed with Tap Pharmaceutical Products Inc. in the United States (a joint venture company between Abbott of the United States ann Takeda of Japan) for its world distribution and marketing rights except Korea and China under a front and milestone payment at $44 million including initial $3.5 mil...